True Wealth Design’s Amicus Therapeutics FOLD Stock Holding History

True Wealth Design’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-893	Closed	-$12.9K	–	2740
2026 Q1	$12.9K	Hold	893	–	–	﹤0.01%	887
2025 Q4	$12.7K	Buy	893 +42	+5%	+$413	﹤0.01%	771
2025 Q3	$6.71K	Buy	+851	New	+$6.06K	﹤0.01%	978

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

True Wealth Design's FOLD Position: Q2 2026 in Review

True Wealth Design sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 893 shares — an estimated $12.9K sold.

True Wealth Design first reported a position in FOLD in Q3 2025 and held it in 3 quarters. The position peaked at $12.9K in Q1 2026. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

True Wealth Design reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
True Wealth Design sold 893 Amicus Therapeutics shares in Q2 2026, an estimated $12.9K.
True Wealth Design first reported a position in Amicus Therapeutics in Q3 2025 and held it in 3 quarters.
True Wealth Design's Amicus Therapeutics position peaked at $12.9K in Q1 2026.
1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.